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Abstract
Background: In this study, we suggested characterizing the vasodilator effects and the phytochemical
characteristics of a plant with food usage also used in traditional treatment of arterial high blood pressure
in Senegal.
Methods: Vascular effects of crude extract of dried and powdered calyces of Hibiscus sabdariffa were
evaluated on isolated thoracic aorta of male Wistar rats on organ chambers. The crude extract was also
enriched by liquid-liquid extraction. The various cyclohexane, dichloromethane, ethyl acetate, butanol
extracts obtained as well as the residual marc were subjected to Sephadex LH-20 column
chromatography. The different methanolic eluate fractions were then analyzed by Thin Layer (TLC) and
High Performance Liquid Chromatography (HPLC) and their vascular effects also evaluated.
Results: The H. Sabdariffa crude extract induced mainly endothelium-dependent relaxant effects. The
endothelium-dependent relaxations result from NOS activation and those who not dependent to
endothelium from activation of smooth muscle potassium channels. The phytochemical analysis revealed
the presence of phenolic acids in the ethyl acetate extract and anthocyans in the butanolic extract. The
biological efficiency of the various studied extracts, in term of vasorelaxant capacity, showed that: Butanol
extract > Crude extract > Residual marc > Ethyl acetate extract. These results suggest that the strong
activity of the butanolic extract is essentially due to the presence of anthocyans found in its fractions 43-67.
Conclusion: These results demonstrate the vasodilator potential of hibiscus sabdariffa and contribute to
his valuation as therapeutic alternative.
Published: 2 November 2009
Nutrition & Metabolism 2009, 6:45 doi:10.1186/1743-7075-6-45
Received: 13 May 2009
Accepted: 2 November 2009
This article is available from: http://www.nutritionandmetabolism.com/content/6/1/45
© 2009 Sarr et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Nutrition & Metabolism 2009, 6:45 http://www.nutritionandmetabolism.com/content/6/1/45
Page 2 of 12
(page number not for citation purposes)
Background
Cardiovascular pathologies complications (myocardial
infarction, stroke...) constitute one of the most important
causes of mortality and morbidity in the world [1-3].
These complications, often facilitated by arterial high
blood pressure, appear among the main causes of death in
Africa. Indeed, according to World Health Organisation
(W.H.O) experts, high blood pressure and hypercholeste-
rolemia are more frequent in the developing countries
than believed. Among the risk factors, except hypercholes-
terolemia, obesity, smoking addict and diabetes consti-
tute the major contributing factors of these diseases[4]. A
future scenario by the W.H.O. reveals a negative trend due
to an increase in the rate of morbidity and mortality espe-
cially in Emerging Countries [1]. Considering the gravity
and the frequency of these conditions, a search for com-
pounds having vascular benefits is intensively pursued
[5]. The interest of researchers in the whole world for
these compounds encouraged us to study the healing
plants of the Senegalese pharmacopoeia. Indeed, an eth-
nobotanical investigation led by our laboratory had listed
several healing plants with antihypertensive potential
among which, Hibiscus sabdariffa L. In the Senegalese
pharmacopoeia,  H. sabdariffa is one of the most-often
used plants in the traditional treatment of high arterial
blood pressure. Previous studies led by numerous groups
of researchers [6-14] had already reported scientific proof
of the antihypertensive effects traditionally attributed to
H. sabdariffa. If these studies allowed demonstrating the
therapeutic potential of this plant, so in vitro as in vivo, the
underlying mechanisms involved as well as the phyto-
chemical compounds responsible for these effects were
not fully documented. So the objective of this study was
to contribute to the understanding of such mechanisms
and the discovery of bioactive substances responsible for
vascular effects of H. sabdariffa. By combining technical
preparation (extraction, enrichment, fractionation) and
phytochemical characterization (TLC, HPLC) combined
with biological characterization methods (organ bath),
we strived to identify the phytochemical compounds and
estimate their vasorelaxant effects.
Methods
Organic extract preparation
H. sabdariffa calyces was obtained from the Tilène market
(Dakar). Calyces were dried during a week at room tem-
perature, to avoid the risks of mold formation because of
the relative humidity of the plant, and also to facilitate its
conservation and its use during the grinding. Dried and
powdered calyx (Grinder RM-100, Retsch®) of Hibiscus
sabdariffa (500 g) was extracted by maceration at room
temperature for 2 hours with 60% methanol. The hydroal-
coholic extract was then filtered in vacuum conditions
(Vacuum pump V-700, Büchi®) by means of the phial of
Kitassato and evaporated on a rotary evaporator
(Rotavapor R-210, Büchi®). Methanolic extract evapora-
tion was realized during three successive days until the
obtaining of a dry crude extract (136.7 g). Evaporation
conditions were as follows: Temperature: +40°C; Cool-
ing: +21°C; Rotation: 4000 tr./min. The methanolic
extract, when not evaporated at once, went through those
stages of separation with cyclohexane, dichloromethane,
ethyl acetate and butanol to end up as an enriched extract
after two hours of decantation. It is repeated as often as
needed with new solvent until exhaustion (colorless
organic phase). The various liquid organic extracts
(cyclohexanic, 1.42 g; dichloromethanic, 2.53 g; ethyl ace-
tate, 34.85 g; butanolic, 18.97 g and the residual marc,
79.01 g) were then washed with anhydrous sodium sul-
phate (Fischer®) to fix some residual water, and then fil-
tered.
Organ bath experiments
Experiments were conducted in accordance with the
Guide for the Care and Use of Laboratory Animals as
promulgated by the Senegalese authorities.
Male Wistar rats weighing 150-200 g were procured from
a local Institute (Faculté des Sciences et Techniques,
Dakar, Senegal). They were fed on standard rat feed and
given free access to water. Thoracic aorta were removed
from rats after anaesthesia with pentobarbital (60 mg/kg,
i.p.) and cleaned of connective tissue and cut into rings
(3-4 mm in length). As indicated, the endothelium was
removed by rubbing the intimal surface of rings with a
pair of forceps.
Rings were suspended in organ baths chambers (Panlab-
TRI 202P) containing oxygenated (95% O2; 5% CO2)
Krebs bicarbonate solution (mM: NaCl 119, KCl 4.7,
KH2PO4 1.18, MgSO4 1.18, CaCl2 1.25, NaHCO3 25 and
D-glucose 11, pH 7.4, 37°C) for determining changes in
isometric tension. Following equilibration for 60 minutes
under a resting tension of 1 g, rings were contracted with
norepinephrine (1 μM) and the relaxation to acetylcho-
line (1 μM) was determined. After washout and a 30 min
equilibration period and return to baseline, rings were
contracted with cumulative concentration of norepine-
phrine (10-8 to 10-5 M), and when the contraction reached
a steady state, a concentration-relaxation curve with
plants extract or solvent (10-4 to 10-1mg/mL), acetylcho-
line (Prolabo) or sodium nitroprusside (10-9 to 3.10-6 M)
was constructed.
Parallel sets of experiments were performed in the pres-
ence of either the NOS inhibitor, L-NAME (300 μM),
cyclooxgenase (COX) inhibitor, Indomethacin (100 μM),
NO scavengers, Oxyhemoglobin (OxyHb, 10 μM) or gua-
nylate cyclase inhibitor, Methylene blue (10 μM). Other
experiments were also conducted by treatment of aorticNutrition & Metabolism 2009, 6:45 http://www.nutritionandmetabolism.com/content/6/1/45
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rings, 30 min before norepinephrine contraction, with the
cell-permeant SOD mimetic, manganese(III) tetrakis(1-
methyl-4-pyridyl)porphyrin (MnTMPyP, 5 μM), the spe-
cific inhibitor of phosphatidyl inositol 3-kinase, Wort-
manin (10 μM), the non-specific potassium channels
inhibitor, Baryum chloride (BaCl2, 30 μM) or Glibencla-
mide (50 μM) which specifically blocks ATP-sensitive
potassium channel.
Phytochemical analysis
- Enriched extracts fractionation
Enriched extracts were fractionated by liquid Chromatog-
raphy on Lipophilic Sephadex LH20®  (Sigma-Aldrich)
according to the following protocol: 40 g of Sephadex
LH20 are conditioned with methanol 20% in a glass col-
umn of 2,3 cm diameter provided with a faucet. The flow
was adjusted in 32 drip/min. 1,5 g of extract were dis-
solved in 5 ml of methanol and deposited on the surface
of the frost.
The extracts were first eluted with 120 ml of methanol/
water (20:80). After the elution of 40 ml of dead volume,
fractions of 200 drops are collected (fractions 1 to 11) by
means of a fraction collector (Spectra/Chrom CF-1®).
Then elution with 100 ml of methanol/water (30:70) for
collection of fractions 12 to 23; 100 ml of methanol/water
(40:60) for collection of fractions 24 to 35; 100 ml of
methanol/water (50:50) for collection of fractions 36 to
50 and 200 ml of methanol 100% for the collection of the
fractions 51 to 67. Then, the frost was washed with 250 ml
of acetone/H2O mixture (50:50) to get the fractions 68 to
80. At the end of the fractionation, fractions of identical
colour are combined to give fractions 1-4, 6-8, 9-15, 16-
18, 19-23, 24-32, 33-42 and 43-67 for the butanolic
extract. The same process of combination was applied to
the other enriched extracts to get fractions 1-15, 16-20, 21-
26, 27-35 and 36-67 for the ethyl acetate extract or crude
extract and fractions 1-10, 11-17, 18-26, 27-40 and 41-67
for the residual marc. Each fraction was evaporated by
rotary evaporator and analyzed by TLC (Silica gel 60 F254,
Merck) and HPLC (Varian Pro Star).
- TLC-fingerprint and HPLC analysis
For the TLC analysis, extracts were dissolved in the migra-
tion solvent of the ethyl acetate/icy acetic acid/formic
acid/water mixture (100:11:11:26). 10 μl of reference
solutions and samples (1 mg/mL) were applied to the TLC
plate. At the end of the migration, TLC Plates were dried
and phytochemical compounds observed under natural
light or after revelation by the NEU reagent (= 1% of
diphenylboryloxyethylamine in methanol) and observa-
tion under UV light in 366 nm. Interpretation of the vari-
ous chromatograms was made on the basis of those
presented in Plant Drug Analysis: 6 am. Wagner, S Bladt
(1996) [15]. Fluorescence can be to interpret in the fol-
lowing way: blue: phenolic Acids; yellow - Orange: Fla-
vonols; Yellow - Green: Flavones.
With the aim of confirming the chemical composition of
the crude extract and determining that of enriched
extracts, we proceeded to an HPLC analysis. For that pur-
pose, we used pure reference substances (chlorogenic
acid, phenolic acid, delphinidin, cyanidin, etc.) of reten-
tion time and length of detection known, for the determi-
nation of the phytochemical profile of our various
extracts. Extracts were examined in the following condi-
tions: Mobile phase in gradient mode constituted by the
mixture anhydrous trifluoroacetic acid 0.1% and ace-
tonitril; debit: 1 ml/min; column C18 (EC 250/4.6 Nucle-
odur 100-10 C 18 ec); Diode array detector between 191
and 700 nm; injection volume: 10 μL.
Materials
Unless otherwise indicated, drugs were purchased from
Sigma Chemical Co or Aldrich (Saint Quentin-Fallavier,
France). Norepinephrine (MISR CO) was a generous gift
from 'Pharmacie Nationale d'Approvisionnement',
Dakar, Senegal). Methanol, butanol, acetic acid, cyclohex-
ane and dichloromethane solutions were purchased from
Fischer Scientific.
Statistical Analysis
Values are expressed as mean ± SEM. Statistical evaluation
was performed with Student's t test for paired data or
ANOVA. Values of p < 0.05 were considered statistically
significant.
Results
Regulatory mechanisms of the hibiscus sabdariffa crude 
extract-induced relaxation
In order to characterize mechanisms involved in the relax-
ing effects of hibiscus sabdariffa, we conducted vascular
reactivity experiments using isolated rat thoracic aortic
rings treated or not with inhibitors.
- Influence of the endothelium
as shown in Figure 1A, Hibiscus sabdariffa crude extract
leads to a weak relaxation (Emax: 23,93% ± 0,48) of aortic
rings without endothelium. However, the observed relax-
ations in rings with endothelium were significantly
greater (Emax: 66,57% ± 8,07). These results suggest that
relaxations induced by h. sabdariffa crude extract are sup-
ported of both endothelium-dependent and independent
mechanisms. However, the endothelium-dependent com-
ponent was much more significant. In comparison with
the endothelium-dependent relaxant agonist acetylcho-
line (Emax: 85,49% ± 3,05) or the nitric oxide donor and
endothelium-independent relaxant agonist sodium nitro-
prusside (Emax: 96,82% ± 1,86), relaxations obtainedNutrition & Metabolism 2009, 6:45 http://www.nutritionandmetabolism.com/content/6/1/45
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Relaxant effect of (A) hibiscus sabdariffa calyces crude extract (10-4 to 10-1g/l) and (B) acetylcholine or sodium nitroprusside  (10-9 to 3 Figure 1
Relaxant effect of (A) hibiscus sabdariffa calyces crude extract (10-4 to 10-1g/l) and (B) acetylcholine or sodium 
nitroprusside (10-9 to 3.10-6 M) in aortic rings with and without endothelium precontracted with norepine-
phrine (10-8 to 10-6M). Values are expressed as mean ± SEM of 9-12 experiments; ns: not significant; * P < 0.05; ** P < 0.01, 
ANOVA.
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Relaxant effect of hibiscus sabdariffa calyces crude extract (10-4 to 10-1g/l) in aortic rings with endothelium (Control) precon- tracted with norepinephrine (10-8 to 10-6M) or after treatment with inhibitors Figure 2
Relaxant effect of hibiscus sabdariffa calyces crude extract (10-4 to 10-1g/l) in aortic rings with endothelium 
(Control) precontracted with norepinephrine (10-8 to 10-6M) or after treatment with inhibitors. Values are 
expressed as mean ± SEM of 4-6 experiments; ns: not significant; *:P < 0.05, ** P < 0.01, in comparison to control.
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with h. sabdariffa crude extract remain less pronounced
(Figure 1B).
As the endothelium was strongly involved in the observed
relaxations, it was necessary to study the role of NO-Syn-
thase (NOS) and Cyclooxgenase (COX), two major
enzymes responsible for the release of relaxing factors in
vascular beds. Using L-NAME and Indomethacin, two
respective inhibitors of these enzymes, our results indicate
that only NOS is activated after administration of the
crude extract. Indeed, Figure 2A shows that L-NAME sig-
nificantly reduced the relaxations, whereas Indomethacin
does not, suggesting a possible stimulation of NO-sGC-
cGMP signaling pathway by the H. sabdariffa crude
extract.
Interestingly, as shown in figure 2B, the NO scavenger
oxyhemoglobin and the soluble guanylate cyclase inhibi-
tor methylene blue significantly reduce the effect of sGC
activation after administration of the H. sabdariffa extract,
leading to a decrease of the observed relaxations.
- NOS-NO-sGC pathway activation
The NO pathway was strongly involved in the relaxation
induced by the crude extract of H. sabdariffa. An interest-
ing question was how this pathway is activated. Activation
of the PI3-kinase/akt pathway leads to phosphorylation of
eNOS, as reported by numerous studies [16-19]. Moreo-
ver, cell-derived reactive oxygen species (ROS), when
present in biological media at physiological concentra-
tions can activate this pathway [20-22]. Our results, as
shown in Figure 2C, show that wortmanin, which specifi-
cally inhibits Phosphatidyl-inositol-3-kinase (Pi3-K), as
well as the SOD mimetic MnTMPyP, were found to reduce
significantly the relaxations obtained with the crude
extract. It is suggested that activation of the lipid kinase
PI3K participate as major regulators in the NOS-initiated
cascades of vasorelaxation induced by h. sabdariffa
extract.
- Potassium channels activation
Relaxations obtained with the crude extract in vessels
without endothelium, even if they are significantly lower
compared with those observed in vessels with intact
endothelium, led us to think a direct relaxing effect of this
extract on vascular muscles. A likely mechanism is an
hyperpolarization after direct activation of potassium
channels. This has been verified by the non-selective
inhibitor of potassium channels, barium chloride
(BaCl2). Indeed, after treatment of vessels with this inhib-
itor, we observed a significant reduction of relaxations
both in vessels with endothelium (Figure 2D), than in
(A) Relaxant effects of various extracts (10-4 to 10-1g/l) of  hibiscus sabdariffa calyx in aortic rings with endothelium pre- contracted with norepinephrine (10-8 to 10-6M) and (B) Com- parative Emax (% values in terms of vasorelaxant effects of  the various enriched extracts Figure 3
(A) Relaxant effects of various extracts (10-4 to 10-1g/
l) of hibiscus sabdariffa calyx in aortic rings with 
endothelium precontracted with norepinephrine (10-
8 to 10-6M) and (B) Comparative Emax (% values in 
terms of vasorelaxant effects of the various enriched 
extracts. Values are expressed as mean ± SEM of 6-8 exper-
iments; ns: not significant; *: P < 0.05, ** P < 0.01, in compari-
son to crude extract as reference.
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Table 1: Comparative study of the biological efficiency in terms of vasorelaxant effects of the various enriched extracts
Crude extract Ethyl acetate extract Butanolic extract Residual marc
EC50 (mg/ml) 4,95.10-2 ± 1,34 4,035.10-2 ± 0,86 0,957.10-2 ± 0,6 5,579.10-2 ± 0,7
Emax (%) 66,57 ± 8,07 34,48 ± 10,59 94,3 ± 0,97 82,44 ± 3,94
The values indicate the mean ± SEM of the EC50 and the Emax obtained from 6-8 experiments.Nutrition & Metabolism 2009, 6:45 http://www.nutritionandmetabolism.com/content/6/1/45
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those without endothelium (data not shown). Moreover,
our results also show that K+-ATP-dependent channels are
not responsible for the endothelium-independent relaxa-
tion, as Glibenclamide, considered as a selective inhibitor
of these channels does not significantly alter relaxations.
Vascular relaxing effects of the various enriched extracts 
studied
Since the relaxations observed with the crude extract are
less than those observed with acetylcholine or sodium
nitroprusside, it was necessary to make enriched extracts
in order to improve the vasorelaxations. Figure 3A shows
that the ethyl acetate extract causes a vasorelaxation signif-
icantly less important than the crude extract taken as ref-
erence. On the other hand, the results obtained with the
butanolic extract show a vasorelaxation significantly more
important than those of the crude extract. However, resid-
ual marc leads a vasorelaxation not significantly different
from those of the crude extract. The biological efficiency
of the various studied extracts in terms of vasorelaxant
capacity was appreciated on the basis of the EC50 and of
the maximal effect (Emax), As indicated (Table 1 and Fig-
ure 3B), the butanolic extract presents a vasorelaxant
potential more important than the other extracts. It is
important to note that cyclohexanic and dichlorometh-
anic extracts were not characterized because of their very
weak return on extraction. Furthermore, these solvent
allow to get rid of constituent's generally unwanted fats,
chlorophylls and by-products.
Table 2: Retention time and relative composition of the crude extract after HPLC analysis and detection in the wavelength of 270 nm
Compounds Retention time (min) Content in 10 mg/mL of extract (in %)
Compound NI 20.31 7.89
Chlorogenic acid 21.30 20.18
Anthocyan NI 24.74 2.58
Phenolic acid NI 25.17 27.66
Compound NI 26.74 6.05
Flavonoid NI 30.21 4.17
Flavonoid NI 31.22 4.18
Flavonoid NI 32.59 5.35
Compound NI 43.89 4.56
NI: not identified.
TLC-fingerprinting of the crude extract of hibiscus sabdariffa Figure 4
TLC-fingerprinting of the crude extract of hibiscus 
sabdariffa. Eluent: mixture of ethyl acetate/icy acetic acid/
formic acid/water (100:11:11:26). Detection: under UV light 
in 366 nm after revelation with the reagent of NEU; Spots: 1 
μg/μl of crude extract followed by the various fractions of 
elution at the same concentration: F1-15, F16-20, F21-26, 
F27-35 and F36-67. Support: Silicagel 60 F254 Merck; Fluo-
rescence: blue = Phenolic Acids; yellow - Orange: Flavonols 
and Yellow - Green: Flavones.Nutrition & Metabolism 2009, 6:45 http://www.nutritionandmetabolism.com/content/6/1/45
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Phytochemical analysis of the various studied extracts
- TLC fingerprint and HPLC analysis of the crude extract
To verify the presence of polyphenolic compounds whose
vasorelaxant effects have already been the subject of
numerous studies, we proceeded to a TLC-fingerprint
analysis of the H. sabdariffa crude extract. As shown in fig-
ure 4, these compounds are indeed present in this extract.
With the aim of confirming the chemical composition of
the crude extract and determining that of enriched
extracts, we proceeded to an HPLC analysis. To do so, we
used pure reference substances (acid chlorogenic, phe-
nolic acid, delphinidin, cyanidin, etc.), as shown in figure
5. The relative composition (expressed in percentage) of
various compounds of the crude extract and their reten-
tion time are indicated in table 2. The corresponding
chronograms (figure 6) show a majority of polyphenolic
compounds. Results reveal a majority of phenolic and
HPLC analyze of pure substances used as references with detection to 270 nm Figure 5
HPLC analyze of pure substances used as references with detection to 270 nm.
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cafeic acids and the presence of flavonoids, anthocyans
and not identified compounds in the crude extract.
- HPLC analysis of enriched extract
With regards to the enriched extracts, our results show the
presence of a majority of phenolic acids detected in 270
nm in the ethyl acetate extract (Figure 7, Table 3) and of
anthocyans detected in 342 nm in the butanolic extract
(Figure 8, table 4). Finally, the residual marc was not the
object of an HPLC analysis because its vasorelaxant capac-
ity is similar to that of the crude extract.
- TLC fingerprint of the butanolic extract
The biggest vasorelaxant capacity of the butanolic extract
and its wealth in anthocyans led to us to fractionate this
extract with the aim of identifying its compounds. Results
(figure 9) show that only fraction 43-67 of the butanolic
extract is rich in anthocyans compared with the other frac-
tions which contain all polyphenolic compounds, in par-
ticular phenolic and chlorogenic acids or flavonoids.
Discussion
The main results of this study demonstrate and confirm
the relaxing effect of hibiscus sabdariffa extracts, espe-
cially on the isolated rat aorta. But even more interesting,
they have helped characterize the possible mechanisms
involved in vasorelaxation while highlighting the link
between this effect and responsible phytochemical com-
pounds.
In terms of vasorelaxation effects, analysis of our results
shows that hibiscus sabdariffa effects are strongly
endothelium-dependent and involve stimulation of NOS
enzyme by the Pi3-K/Akt pathway. Indeed, the dominant
Table 3: Retention time and relative composition of the ethyl acetate extract after HPLC analysis and detection in the wavelength of 
270 nm
Compounds Retention time (min) Content in 10 mg/mL of extract (in %)
Chlorogenic acid 19.66 4.46
Caffeic acid 22.52 1.97
Phenolic acid NI 23.64 4.91
Phenolic acid NI 24.54 2.38
Compound NI 26.40 4.13
Phenolic acid NI 27.33 1.58
Phenolic acid NI 29.22 2.77
Compound NI 43.79 5.03
NI: not identified.
Table 4: Retention time and relative composition of the butanolic extract after HPLC analysis and detection in the wavelength of 342 
nm
Compounds Retention time (min) Content in 10 mg/mL of extract (in %)
Chlorogenic acid 20.16 12.08
Anthocyan NI 24.01 14.67
Anthocyan NI 25.67 5.51
Flavonoid NI 29.90 11.09
Flavonoid NI 30.93 8.37
Phenolic acid NI 38.76 7.06
NI: not identified.Nutrition & Metabolism 2009, 6:45 http://www.nutritionandmetabolism.com/content/6/1/45
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role of the endothelium in vessel relaxation by plant
polyphenols has already been demonstrated in numerous
works [20,22-32]. Our results also are in agreement with
data obtained from red wine polyphenolic compounds
(RWPC) which activate enzymes involved in the release of
endothelial relaxant factors including eNOS [27,33,34].
Moreover, our results are also in agreement with the idea
that RWPC promotes the release of endothelial NO
through a redox sensitive PI3/Akt pathway [22]. Finally,
these results also contrast with one of our previous study
[21] where it was interesting to note that the mechanism
by which cognac polyphenolic compounds (CPC)
enhances NO production does not involve redox system.
Data obtained with this previous study demonstrate that
CPC is able to directly increase NO production without
affecting superoxide anions and enhances the bradykinin-
induced NO production in human endothelial cells.
Our results also show a non-endothelium-dependent
relaxation induced by the h. sabdariffa extract, which has
not been the case for most other types of polyphenolic
extracts. The likely mechanism of this non-endothelium-
dependent relaxation is a direct smooth muscle activa-
tion. Indeed, H. sabdariffa as shown by our results, can
also relax blood vessels without endothelium, and it was
also admitted that the endothelium hyperpolarized factor
Phytochemical profile of the ethyl acetate extract after HPLC analysis and detection in 270 nm Figure 7
Phytochemical profile of the ethyl acetate extract after HPLC analysis and detection in 270 nm.
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Phytochemical profile of the butanolic extract after HPLC analysis and detection in 342 nm Figure 8
Phytochemical profile of the butanolic extract after HPLC analysis and detection in 342 nm.
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(EDHF) is only marginally involved in endothelium-
dependent relaxation in rat aorta [35-38]. The results of
this present study strongly suggest that direct activation of
smooth muscle may be caused by a membrane hyperpo-
larization after activation of vascular potassium channels.
However, if we can exclude the role of K+-ATP-dependent
channels, it would be interesting in the future to examine
the role of K+ calcium-dependent channels (IKCa, SKCa).
Numerous past studies have shown the effectiveness of
Hibiscus sabdariffa in the treatment of high arterial blood
pressure and other cardiovascular diseases [6-14]. If these
studies, most often made from in vivo models, have
already shown the biological efficiency of organic extracts
of this plant, they simultaneously demonstrate the bioa-
vailability of various constituents of hibiscus sabdariffa in
biological media. The quantities of extracts to absorb will
depend on the disease to treat and should be seriously
studied. However, it is interesting to note the low toxicity
of this plant for which toxic doses are around 2000 mg/kg
[39].
On the phytochemical composition of different extracts,
taking into account bibliographical knowledge [40,41],
we proceeded to the enrichment of the crude extract by
liquid extraction - liquid with solvents of increasing polar-
ity to obtain various types of enriched extracts. The
cyclohexanic extract allowed us to get rid of apolar constit-
uents, generally unwanted fats, chlorophylls and by-prod-
ucts; The dichloromethanic extract allowed us to
concentrate compounds such as terpenes, flavonoïd agly-
cones, coumarins, phenolic acids; the ethyl acetate extract
allowed us to concentrate compounds such as flavonoïd
aglycones and glycosides, phenolic acids, tannins; The
butanolic extract allowed us to concentrate compounds
such as flavonoïds di- and triglycerides, phenolic acids,
tannins and anthocyans; the aqueous residual extract con-
taining the rest of compounds not pulled by these sol-
vents. The phytochemical composition of the various
extracts was determined by HPLC analysis which presents
numerous advantages compared with methods reported
in various other works [10]. The end results, which
showed a presence of polyphenols in the various exam-
ined extracts, are in line with the information given by
Berhault and al. [42] as well as the works led by Lin et al.
[43] and Kao et al. [44]. The only new information is the
fact that the butanolic extracts, in addition to aroused
polyphenols, contain mainly anthocyans.
Our study also showed that on adrenalin-precontracted
isolated aortic rings, the crude hydro-alcoholic extract of
Hibiscus sabdariffa induced a vasorelaxation. This relaxa-
tion is dose-dependent. It reaches a value of 66,57% ±
8,07 for the maximal concentration administrated i.e. 10-
1 mg/ml. These results concur with those of Ajay et al. [9]
who showed that for a concentration of 1 mg/ml, he
noted a maximal relaxation of 86% ± 4,84. However it is
to note that they worked in vitro with a model of sponta-
neously hypertensive rats while we worked with normal
rats.
The observed vasorelaxation is more important with the
butanolic extract for which the maximal effect is about
94,3 ± 0,97% at a concentration of 10-1 mg/ml in compar-
ison with the maximal relaxation observed with the crude
extract. However, the effect of the residual extract is less
important than that of the butanolic and the crude
extracts; and that of the ethyl acetate extract is even less. In
light of these results, it appears that our study confirmed
that the hydro-methanolic total extract of the dried calyces
of H. sabdariffa possess an important vasorelaxant activity;
and that the enriched butanolic extract of the dried calyces
possess an vasorelaxant activity even more important.
Numerous studies reported the presence and the nature of
some anthocyans of H. sabdariffa [10,36,41,45-50]. As for
the Senegalese variety of H. sabdariffa, we note especially
cyanidin by-products such as cyanidin-3-monoglucoside,
TLC-fingerprinting of the various fractions of the butanolic  extract of hibiscus sabdariffa Figure 9
TLC-fingerprinting of the various fractions of the 
butanolic extract of hibiscus sabdariffa. Eluent: mix-
ture of ethyl acetate/icy acetic acid/formic acid/water 
(100:11:11:26). Detection: in natural light without revealing; 
Spots: 1 μg/μl of butanolic extract followed by various frac-
tions of elution at the same concentration: F1-4, F6-8, F9-15, 
F16-18, F19-23, F24-32, F33-42 and F43-67. Support: Sili-
cagel 60 F254 Merck;Nutrition & Metabolism 2009, 6:45 http://www.nutritionandmetabolism.com/content/6/1/45
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cyanidin-3,5-diglucoside, cyanidin-3-sambubioside [51].
After analysis, it seems that the strong vasorelaxant activity
of the butanolic extract, compared with the other extracts,
would be due for many to the presence of these anthocy-
ans in his fraction 43-67. Finally, the weak quantities of
extraction of this fraction did not allow us to test it on iso-
lated rat thoracic aorta.
To the best of our knowledge, such results (the link
between the vasorelaxant property and the anthocyans
present in H. Sabdariffa) have not been reported in the lit-
erature. They thus constitute one of the originalities of our
work which is to be continued, to characterize and isolate
these anthocyans as well as their molecular mechanisms
in the induced vasorelaxation.
Conclusion
Hibiscus sabdariffa could be an alternative in the care of
vascular diseases in our countries, considering its low cost
and its availability. It is also necessary to emphasize the
preventive role that Hibiscus sabdariffa could play. This is
all the easier to realize as it is about a plant known, and
currently used, by local populations. It would be neces-
sary to make the populations aware of these virtues and to
encourage its consumption.
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